The New Idea Award is a concept award to support innovative approaches that may fundamentally change the understanding, diagnosis and/or treatment of blood cancers and related pre-malignant conditions.
This grant program is designed to identify novel research strategies with a potential for high impact on blood cancer. Specifically, this program supports the initial exploration of untested but potentially transformative ideas that challenge our knowledge of blood cancer or the manner in which we approach diagnosis or treatment. Competitive proposals will describe ideas that take the investigator’s research in a substantially new direction, and thus preliminary data is not required.
The goal of this program is to advance novel concepts that may eventually lead to significant improvements in the clinical outcomes of patients with hematological malignancies. In addition to applications from blood cancer researchers, we strongly encourage applications from those with expertise outside of blood cancer, with the goal of stimulating new research.
In order to receive such an award, applicants must succinctly describe as one aim the innovative idea/approach and a method for testing it within the one year grant period. Grants will be awarded in an amount of up to $75,000 for a one year period.
Investigators in academic laboratories are eligible to apply. Researchers in any field are encouraged to apply, but the proposal must directly address blood cancer. Investigators must demonstrate that their research environment is equipped and suitable for the proposed study; this includes demonstrated access to patient materials, where applicable.
Collaboration between multiple investigators to strengthen the proposed research will be considered favourably, but is not a requirement. Applicants must have a faculty appointment at a Canadian university to qualify for funding.
Applicants should hold a Ph.D., M.D., D.V.M. or equivalent degree.